228 related articles for article (PubMed ID: 22355490)
1. Radiotherapy in the treatment of gastrointestinal stromal tumor.
Knowlton CA; Brady LW; Heintzelman RC
Rare Tumors; 2011 Oct; 3(4):e35. PubMed ID: 22355490
[TBL] [Abstract][Full Text] [Related]
2. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for Gastrointestinal Stromal Tumors.
Ozkan EE
Chin Med J (Engl); 2018 Jan; 131(2):235-240. PubMed ID: 29336374
[TBL] [Abstract][Full Text] [Related]
4. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.
Keung EZ; Fairweather M; Raut CP
Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287
[TBL] [Abstract][Full Text] [Related]
5. Current management of gastrointestinal stromal tumors--a comprehensive review.
Lai EC; Lau SH; Lau WY
Int J Surg; 2012; 10(7):334-40. PubMed ID: 22633986
[TBL] [Abstract][Full Text] [Related]
6. Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs).
Vetto JT
Onco Targets Ther; 2009 Feb; 2():151-9. PubMed ID: 20616902
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.
Nishida T; Doi T; Naito Y
Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report.
Kimura T; Togawa T; Onishi K; Iida A; Sato Y; Goi T
J Investig Med High Impact Case Rep; 2020; 8():2324709620970736. PubMed ID: 33228387
[TBL] [Abstract][Full Text] [Related]
9. [Gastrointestinal stromal tumors (GIST) of the stomach as a cause of upper gastrointestinal bleeding].
Ebrahimi K; Velicković D; Spica B; Sabljak P; Bjelović M; Stojakov D; Micev M; Dunjić M; Pesko P
Acta Chir Iugosl; 2007; 54(1):115-8. PubMed ID: 17633870
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
11. Gastrointestinal stromal tumors: imatinib and beyond.
Schnadig ID; Blanke CD
Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
[TBL] [Abstract][Full Text] [Related]
12. Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor.
Lolli C; Pantaleo MA; Nannini M; Saponara M; Pallotti MC; Scioscio VD; Barbieri E; Mandrioli A; Biasco G
Rare Tumors; 2011 Oct; 3(4):e49. PubMed ID: 22355504
[TBL] [Abstract][Full Text] [Related]
13. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
Demetri GD
Semin Oncol; 2001 Oct; 28(5 Suppl 17):19-26. PubMed ID: 11740803
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumors (GIST) related emergencies.
Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
[TBL] [Abstract][Full Text] [Related]
15. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
Demetri GD
Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773
[TBL] [Abstract][Full Text] [Related]
16. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
17. [A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)].
Miyake M; Takeda Y; Hasuike Y; Kashiwazaki M; Mishima H; Ikenaga M; Mano M; Takada Y; Hirota S; Tsujinaka T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1791-4. PubMed ID: 15553717
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors.
Iwatsuki M; Harada K; Iwagami S; Eto K; Ishimoto T; Baba Y; Yoshida N; Ajani JA; Baba H
Ann Gastroenterol Surg; 2019 Jan; 3(1):43-49. PubMed ID: 30697609
[TBL] [Abstract][Full Text] [Related]
19. [Treatment strategy for marginally resectable GIST].
Kanda T; Ishikawa T; Ozaki T; Yajima K; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1266-70. PubMed ID: 21829064
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal Carcinomatosis as an Initial Presentation of Gastrointestinal Stromal Tumor: A Case Report and Review of the Literature.
Ozcan G; Gautam G; Da Cunha T; Becker EC; Perosevic N
Cureus; 2022 Jun; 14(6):e26421. PubMed ID: 35785012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
